Phase 3 Readout~month

Phase 3 Topline: A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the

Indication
Respiratory Syncytial Virus Infections

Other upcoming events for TCBWF

Phase 3 ReadoutPhase 3 Topline: A Multicenter, Randomized, Open-Label, Positive-Controlled Phase III Clinical Trial to Study the Eff
Phase 3 ReadoutPhase 3 Topline: A Multicenter, Randomized, Open-Label, Positive-Controlled Phase III Clinical Trial to Study the Eff

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the — TCBWF Phase 3 Readout | BioSniper